Junhua Wu

12PUBLICATIONS
10CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 03, 2026
Leveraging multimodal cancer immunotherapy to amplify the efficacy of oncolytic viruses.

|Mar 17, 2026
Thymopentin enhances adenoviral oncolytic therapy by regulating macrophages and CD8+ T cells.

Lingkai Kong, Kua Liu, Yan Liu

|Feb 06, 2025
Correction: SENP3 inhibition suppresses hepatocellular carcinoma progression and improves the efficacy of anti-PD-1 immunotherapy.

Peng Wang, Jiannan Qiu, Yuan Fang

|Jan 04, 2025
SENP3 inhibition suppresses hepatocellular carcinoma progression and improves the efficacy of anti-PD-1 immunotherapy.

Peng Wang, Jiannan Qiu, Yuan Fang

|Jun 26, 2024
"Find Me" and "Eat Me" signals: tools to drive phagocytic processes for modulating antitumor immunity.

Lingjun Xiao, Louqian Zhang, Ciliang Guo

|Mar 26, 2024
Ezetimibe inhibits the migration and invasion of triple-negative breast cancer cells by targeting TGFβ2 and EMT.

Lingkai Kong, Qinyu He, Ding Ma

Pageof 2

Frequent Collaborators

3 joint publications

Peng Wang

3 joint publications

Xiaosong Gu

2 joint publications

Zhongxia Wang

2 joint publications

Chunping Jiang